No Detail Found!

Invasive Ductal Carcinoma: Correlation of Immunophenotypic Features with Age.

Author(s)
Fouzia Lateef Department of Histopathology, Dr. Ziauddin University Hospital, Karachi, Pakistan
Saba Jamal Department of Histopathology, Dr. Ziauddin University Hospital, Karachi, Pakistan
Surrayya Nasir Department of Histopathology, Dr. Ziauddin University Hospital, Karachi, Pakistan
Zainab Jamil Department of Histopathology, Dr. Ziauddin University Hospital, Karachi, Pakistan
Abstract
Objective: To evaluate the frequency of hormone receptors and Her2neu expression and their correlation with age in patients of carcinoma breast. Study Design: Descriptive, cross-sectional study. Place and Duration of Study: Department of Histopathology, Dr. Ziauddin Hospital, Karachi, between the period 2006 - 2013. Methodology: Estrogen receptors, progesterone receptors and Her2neu immunohistochemical staining was performed on all specimens of carcinoma breast of female patients. Allred scoring was followed using normal epithelium as internal control. Age was determined in years. Results were described as percentages. Results: Three hundred and forty-six cases of infiltrating ductal carcinoma of breast between the age of 20 - 90 years (mean= 49 ±14 years) were studied. Seventy-nine (23%) cases were below the age of 40 years. ER +ve cases were 210 (61%), PR +ve were 190 (55%), and 78 (23%) were Her2neu +ve. Three were 12 (3%) triple positive cases and 58 (17%) triple negative cases. One hundred and seven (31%) cases were ER/PR+ve and Her2neu -ve. Most of the breast cancer cases were aged between 41 - 50 years. Estrogen receptor positivity was maximum between 41 - 60 years. Fifty percent cases of carcinoma breast below 30-year age were also ER positive. Conclusion: A high proportion of breast cancer in young Pakistani females is alarming. Younger age harbours aggressive clinicopathologic characteristics. There is a due need for identifying high risk individuals/families including BRCA1 and BRCA2 testings, biologically driven trials devoted specifically to this group.
Publication Details
Page(s) 18-22
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 27, Issue: 1, Year: 2017

Request the full text from PASTIC

Keywords
Infiltrating ductal carcinoma. Estrogen receptor. Progesterone receptors. Her2neu. Age. Immunohistochemistry status.
References
RazaU,KhanamA,FurqanM, 2010.Risk profile for breast carcinoma and tumour histopathology of medical uninsured patients in Pakistan,JAMC 23 9 -14
TanwaniAK, 2009.Pattern of invasive ductal carcinoma of breast according to Nottingham Prognostic Index,Ann Pak Inst Med Sci 5 251 -4
FitzgibbonsPL,DillonDA,AlsabehR,BermanMA,HayesDF,HicksDG, 2014.Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast,Arch Pathol Lab Med 138 595 -601
FaheemM,MahmoodH,KhurramM,QasimU,IrfanJ, 2012.Estrogen receptor, progesterone receptor, and Her2neu positivity and its association with tumour characteristics and menopausal status in a breast cancer cohort from northern Pakistan,Ecancer Medical Science 6 283 -
DekkerT,SmitV,HooijerG,Van de VijverM,MeskerW,TollenaarR, 2013.Reliability of core needle biopsy for determining ER and Her2 status in breast cancer,Ann Oncol 24 931 -7
BadarF,MahmoodS,FarazR,YousafA,Ain, 2015.Epidemiology of breast cancer at the Shaukat Khanum Memorial Cancer Hospital,J Coll Physicians Surg Pak 25 738 -42
BouchbikaZ,BenchakrounN,TalebA,JouhadiH,TawfiqN,SahraouiS, 2012.Association between over expression of Her-2 and other clinicopathologic prognostic factors in breast cancer in Morocco,J Cancer Ther 3 787 -92
DeshpandeAK,ErukkambattuJ,PrabhalaS,Tanikella R. ER PR, 2015.Her2/neu markers carcinoma breast immunohistochemistry. Expression of estrogen, progesterone and Her2/neu receptors in breast carcinoma-study in a tertiary care hospital,JEMDS 4 10170 -7
MohammadianK,PashakiAS,HamedEA,BehnoodS,AbassiM,BabaeiM, 2014.Association between immunohistochemical profile and clinicopathological appearance in breast cancer: A 7-year review from Mahdieh Radiotherapy Center,Iran. Rep Radiother Oncol 1 103 -7
TamakiK,SasanoH,IshidaT,MiyashitaM,TakedaM,AmariM, 2010.Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and Her2 status of breast cancer patients,Cancer Sci 101 2074 -9
NwaforCC,KeshinroSO, 2015.Pattern of hormone receptors and human epidermal growth factor receptor 2 status in subSaharan breast cancer cases: Private practice experience,Niger J Clin Pract 18 553 -8
AndersCK,JohnsonR,LittonJ,PhillipsM,BleyerA, 2009.Breast cancer before age 40 years,Semin Oncol 36 237 -49
AmbroiseM,GhoshM,MallikarjunaV,KurianA, 2011.Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India,Asian Pac J Cancer Prev 12 625 -9
BhagatVM,JhaBM,PatelPR, 2012.Correlation of hormonal receptor and Her-2/neu expression in breast cancer: A study at tertiary care hospital in South Gujarat,Nat J Med Res 2 295 -8
PatnayakR,JenaA,RukmangadhaN,ChowhanAK,SambasivaiahK,PhaneendraBV, 2015.Hormone receptor status (estrogen receptor, progesterone receptor), human epidermal growth factor-2 and p53 in South Indian breast cancer patients: A tertiary care center experience,Indian J Med Paediatr Oncol 36 117 -22
Vona-DavisL,RoseDP,HazardH,Howard-McNattM,AdkinsF,PartinJ, 2008.Triple-negative breast cancer and obesity in a rural Appalachian population,Cancer Epidemiol Biomarkers Prev 17 3319 -24
AlluriP,NewmanLA, 2014.Basal-like and triple-negative breast cancers: Searching for positives among many negatives,Surg Oncol Clin N Am 23 567 -77
OnitiloAA,EngelJM,GreenleeRT,MukeshBN, 2009.Breast cancer subtypes based on ER/PR and Her2 expression: Comparison of clinicopathologic features and survival,Clin Med Res 7 4 -13
VoinescuDC,CiobotaruOR,SinA,BarnaO,ComanM,CiobotaruOC, 2015.Study of Her2, ER and PR markers and survival in invasive ductal carcinoma patients in south-east Romania,Biotechnol Biotechnol Equip 29 1135 -41
YouldenDR,CrambSM,YipCH,BaadePD, 2014.Incidence and mortality of female breast cancer in the Asia-Pacific region,Cancer Biol Med 11 101 -15
LeongSP,ShenZZ,LiuTJ,AgarwalG,TajimaT,PaikNS, 2010.Is breast cancer the same disease in Asian and Western countries?,World J Surg 34 2308 -24
GhoshJ,GuptaS,DesaiS,ShetT,RadhakrishnanS,SuryavanshiP, 2011.Estrogen, progesterone and Her2 receptor expression in breast tumors of patients, and their usage of Her2-targeted therapy, in a tertiary care centre in India,Indian J Cancer 48 391 -6
SajidMT,AhmedM,AzharM,MustafaQU,ShukrI,AhmedM, 2014.Age-related frequency of triple negative breast cancer in women,J Coll Physicians Surg Pak 24 400 -3
McGuireA,BrownJA,MaloneC,McLaughlinR,Kerin MJ, 2015.Effects of age on the detection and management of breast cancer,Cancers 7 908 -29
SivakumarP,RaviC, 2015.Breast cancer in young women: The effect of age on tumor biology and prognosis,Clin Cancerinvestig J 4 165 -9
0

Citations

0

Downloads

75

Views